» Articles » PMID: 9185683

Beta-Amyloid (A Beta) Deposition in the Medial Temporal Lobe of Patients with Dementia with Lewy Bodies

Overview
Journal Neurosci Lett
Specialty Neurology
Date 1997 May 23
PMID 9185683
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The distribution and density of diffuse, primitive and classic beta-amyloid (A beta) deposits in the medial temporal lobe (MTL) was studied in cases of dementia with Lewy bodies (DLB) with and without associated Alzheimer's disease (AD) and 15 cases of sporadic AD. In the 'pure' DLB cases, virtually no A beta deposits were observed in the CA regions of the hippocampus or dentate gyrus whereas deposits were distributed throughout the MTL in DLB/AD and AD cases. Densities of diffuse and primitive A beta deposits were similar in AD and DLB/AD cases but density was significantly reduced in the 'pure' DLB cases. The density of the classic deposits was significantly reduced in DLB cases with or without associated AD compared with AD cases. These results suggest that A beta deposition in the MTL in 'pure' DLB cases is similar to that of elderly non-demented patients while, with the exception of the classic deposits, A beta deposition in DLB/AD cases is similar to that in cases of AD alone.

Citing Articles

α-Synuclein Aggregation Is Triggered by Oligomeric Amyloid-β 42 via Heterogeneous Primary Nucleation.

Vadukul D, Papp M, Thrush R, Wang J, Jin Y, Arosio P J Am Chem Soc. 2023; 145(33):18276-18285.

PMID: 37556728 PMC: 10450681. DOI: 10.1021/jacs.3c03212.


Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.

Lloyd G, Dhillon J, Gorion K, Riffe C, Fromholt S, Xia Y Mol Neurodegener. 2021; 16(1):63.

PMID: 34503546 PMC: 8427941. DOI: 10.1186/s13024-021-00486-9.


Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology.

Ivanova M, Lin Y, Lee Y, Zheng J, Ramamoorthy A Biophys Chem. 2020; 269:106507.

PMID: 33254009 PMC: 10317075. DOI: 10.1016/j.bpc.2020.106507.


Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson's disease with dementia.

Yedlapudi D, Xu L, Luo D, Marsh G, Todi S, Dutta A Sci Rep. 2019; 9(1):19648.

PMID: 31873106 PMC: 6927976. DOI: 10.1038/s41598-019-55830-3.


Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson's disease.

Murakami H, Tokuda T, El-Agnaf O, Ohmichi T, Miki A, Ohashi H BMC Neurol. 2019; 19(1):113.

PMID: 31164098 PMC: 6549316. DOI: 10.1186/s12883-019-1346-y.